References
- Agarwal, A., Gupta, S., and Sharma, R.K., 2005. Role of oxidative stress in female reproduction. Reproductive biology and endocrinology, 3, 28.
- Ali, H.A., Ali, I.H.M., and Ibrahim, S.A., 2015. The role of inflammation and oxidative stress in the pathogenesis of polycystic ovary syndrome. Word journal of pharmacy and pharmaceutical sciences, 4 (5), 316–323.
- Castro, A.V., et al., 2014. Obesity, insulin resistance and comorbidities? Mechanisms of association. Arquivos brasileiros de endocrinologia e metabologia, 58 (6), 600–609.
- Deba, Z., et al., 2017. Study of levels of malondialdehyde, super oxide dismutase and hsCrp in serum of non-obese patients with polycystic ovarian syndrome. International journal of clinical biochemistry and research, 4 (2), 191–194.
- Desai, V., et al., 2014. Oxidative stress in non-obese women with polycystic ovarian syndrome. Journal of clinical and diagnostic research, 8 (7), CC01–CC03.
- Dunaif, A., et al., 1989. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes, 38 (9), 1165–1174.
- Fenkci, V., et al., 2003. Decreased total antioxidant status and increased oxidative stress in women with polycystic ovary syndrome may contribute to the risk of cardiovascular disease. Fertility and sterility, 80 (1), 123–127.
- González, F., et al., 2006. Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome. Journal of clinical endocrinology and metabolism, 91 (1), 336–340.
- Huber-Buchholz, M.-M., Carey, D.G.P., and Norman, R.J., 1999. Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone. The journal of clinical endocrinology and metabolism, 84 (4), 1470–1474.
- Karabulut, A.B., et al., 2012. Oxidative stress status, metabolic profile and cardiovascular risk factors in patients with polycystic ovary syndrome. Medicine science, 27 (6), 378–334.
- Kitzinger, C., and Willmott, J., 2002. The thief of womanhood': women's experience of polycystic ovarian syndrome. Social science and medicine, 54 (3), 349–361.
- Lee, J.Y., et al., 2010. Role of oxidative stress in polycystic ovary syndrome. Current women’s health reviews, 6 (2), 96–107.
- Li, C., et al., 2009. Prevalence of pre-diabetes and its association with clustering of cardio metabolic risk factors and hyperinsulinemia among U.S. adolescents: National Health and Nutrition Examination Survey 2005–2006 American Association. Diabetes care, 32 (2), 342–347.
- Luque-Ramirez, M., and Escobar-Morreale, H.F., 2014. Polycystic ovary syndrome as a paradigm for prehypertension, pre-diabetes, and pre-obesity. Current hypertension reports, 16 (12), 500–503.
- Mahfouz, R., et al., 2009. Diagnostic value of the total antioxidant capacity (TAC) in human seminal plasma. Fertility and sterility, 91 (3), 805–811.
- Mandal, B., et al., 2010. Assessment of oxidative stress in patients of diabetes mellitus with and without complications. Journal of Indian academy of clinical medicine, 11 (1), 20–25.
- Mark, P.T., 2011. Defining prediabetes in polycystic ovarian syndrome. Open journal of obstetrics and gynaecology, 1, 36–41.
- Moran, L.J., et al., 2011. Lifestyle changes in women with polycystic ovary syndrome. The cochrane database of systematic reviews, 2, 7–10.
- Negishi, H., et al., 2015. Insulin resistance in nonobese Japanese women with polycystic ovary syndrome is associated with poorer glucose tolerance, delayed insulin secretion, and enhanced insulin response. Reproductive medicine and biology, 14 (3), 123–129.
- Palacio, J.R., et al., 2006. The presence of antibodies to oxidative modified proteins in serum from polycystic ovary syndrome patients. Nature immunology, 7 (3), 217–222.
- Sabuncu, T., et al., 2001. Oxidative stress in polycystic ovary syndrome and its contribution to the risk of cardiovascular disease. Clinical biochemistry, 34 (5), 407–413.
- Sundharan, S.M., et al., 2016a. High sensitivity–c reactive protein as an additional marker for increased risk of cardiovascular disease in patients of polycystic ovary syndrome. International journal of clinical biochemistry and research, 3 (3), 308–311.
- Sundharan, S.M., et al., 2016b. Oxidative stress versus inflammation, a better predictor of cardiovascular disease risk in polycystic ovary syndrome. International journal of research in medical sciences, 4 (9), 4010–4013.
- Tehrani, F.R., et al., 2014. The prevalence of metabolic disorders in various phenotypes of polycystic ovary syndrome: a community based study in Southwest of Iran. Reproductive biology and endocrinology, 12 (1), 89.
- Trujillo, M.E., and Scherer, P., 2006. Adipose tissue-derived factors: impact on health and disease. Endocrine reviews, 27 (7), 762–778.
- Unni, N.C., et al., 2015. Evaluation of oxidative stress and hsCRP in polycystic ovarian syndrome in a tertiary care hospital. Indian journal of clinical biochemistry, 30 (4), 418–166.
- Velez, L.M., and Motta, A.B., 2014. Association between polycystic ovary syndrome and metabolic syndrome. Current medicinal chemistry, 21 (35), 3999–4012.
- Wild, R.A., 2002. Long-term health consequences of PCOS. Human reproduction update, 8 (3), 231–241.
- Zhang, D., et al., 2008. The effects of oxidative stress to PCOS. Sichuan da xue xue bao yi xue ban, 39 (3), 421–423.
- Zuo, T., Zhu, M., and Xu, W., 2016. Roles of oxidative stress in polycystic ovary syndrome and cancers. Oxidative medicine and cellular longevity, 2016, 8589318.